New Prospective Study Shows Significant Reduction In Reports Of Postoperative Halos From Patients Treated With TearScience LipiFlow Treatment Prior To Bilateral Cataract Surgery ...Middle East

SANTA ANA, Calif., July 24, 2021 /PRNewswire/ -- Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today revealed new comparative clinical study findings evaluating TearScience LipiFlow treatment in cataract surgery....

Hence then, the article about new prospective study shows significant reduction in reports of postoperative halos from patients treated with tearscience lipiflow treatment prior to bilateral cataract surgery was published today ( Saturday 24/07/2021 - 04:30 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New Prospective Study Shows Significant Reduction In Reports Of Postoperative Halos From Patients Treated With TearScience LipiFlow Treatment Prior To Bilateral Cataract Surgery )

Also on site :

• Ukraine has violated Victory Day ceasefire – Moscow
• Google’s plan to win the AI health race? Play nice with Apple and other rivals
• How a Tory MP 37 years ago has inspired a Labour MP’s ‘stalking horse’ leadership challenge to Starmer